We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cutting-Edge Lab Automation System Supports High-Volume Needs and Provides Faster Results

By LabMedica International staff writers
Posted on 19 Dec 2023

A new, innovative automation solution for clinical labs featuring smart technology can boost lab performance and flexibility, reduce turnaround time, and eliminate 80% of manual steps, thereby increasing reliability and minimizing errors to provide quicker lab results

Abbott’s (Lake Forest, IL, USA) GLP systems Track is a cutting-edge technology and scalable automation solution that helps laboratories meet high-volume demand and maximize productivity. More...

This system introduces innovative features that boost safety, productivity, and capacity to meet increasing laboratory demands. The flexibility of the GLP systems Track is a standout feature, offering laboratories the ability to tailor the system’s configuration to their specific requirements. A key innovation in this system is the CAR, a smart, self-propelled single sample carrier, which allows samples to move independently, not attached to rigid, fixed mechanized track systems. This innovation minimizes mechanical breakdowns that could halt operations, ensuring continuous functionality and adaptability to the lab's evolving needs.

Laboratory results influence up to 70% of medical decisions, and Abbott’s GLP systems Track significantly enhances healthcare quality by automating laboratory processes and aiming to reduce healthcare costs. Its state-of-the-art technology streamlines and simplifies lab tasks. This automation solution transforms sample sorting and transportation, allowing for automatic sample movement throughout the system. It is tailored to meet each lab's unique requirements, effectively managing demand and boosting overall output. The system integrates seamlessly with lab staff workflows, enhancing efficiency and safeguarding lab worker health by reducing direct contact with patient blood samples and lessening exposure to biomedical waste. Capable of handling up to 25,000 test tubes daily across various care settings, this system improves patient test result turnaround times. It also aids in decreasing operational expenses and minimizing manual errors. Abbott's GLP systems Track has received approval from the U.S. Food and Drug Administration (FDA) and is now available in the United States.

“We know that our customers are seeking flexibility and scalability in their laboratory operations so they can meet ever-growing demand,” said Louis Morrone, executive vice president for Abbott’s core diagnostics business. “GLP systems Track addresses those needs, enabling labs to increase performance and improve the overall quality of their operations.”

Related Links:
Abbott


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier decision-making in multiple psychiatric conditions (photo credit: Shutterstock)

Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

Delays in diagnosing serious psychiatric conditions can leave patients without timely support and complicate treatment planning. For bipolar disorder, average time to diagnosis can exceed nine years, and... Read more

Molecular Diagnostics

view channel
Image: The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine (Photo courtesy of ©Science China Press)

Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about 30% of people worldwide and can advance to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.